IN THE THREE DAY PERIOD AFTER ONSET OF SYMPTOMS, SERIAL DETERMINATIONS OF BLOOD SERUM CPK AND LDH ISOENZYMES REMAIN THE BEST LABORATORY AID FOR EARLY DIAGNOSIS OF ACUTE MYO- CARDIAL INFARCTION.

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 4983
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1986
Solitcitation Year: N/A
Solitcitation Topic Code: N/A
Solitcitation Number: N/A
Small Business Information
Haber Inc
470 Main Road, Towaco, NJ, 07082
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 LESLIE OPPENHEIMER
 PRINCIPAL INVESTIGATOR
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract
IN THE THREE DAY PERIOD AFTER ONSET OF SYMPTOMS, SERIAL DETERMINATIONS OF BLOOD SERUM CPK AND LDH ISOENZYMES REMAIN THE BEST LABORATORY AID FOR EARLY DIAGNOSIS OF ACUTE MYO- CARDIAL INFARCTION. THE PHASE I GOAL IS TO DEVELOP A RAPID,COST-EFFECTIVE, HIGH-PRECISION, DIAGNOSTIC ISOENZYME TEST UTILIZING HABER'S ADVANCED SEPARATION TECHNOLOGY, ELECTRO- MOLECULAR PROPULSION (EMP). IN THIS STUDY, DIFFERENT EMP MEDIA WILL BE EXAMINED FOR THEIR ABILITY TO SEPARATE CPK ANDLDH ISOENZYMES. ALSO, METHODS WILL BE DEVELOPED FOR THEIR RAPID DETECTION AND QUANTITATION. DURING PHASE II, HABER PROPOSES TO FURTHER IMPROVE AND DEVELOP THE METHODOLOGY AND TO PROTOTYPE A DIAGNOSTIC TEST FOR USE IN THE CLINICAL LABORATORY. HABER, WITH ITS ADVANCED EMP SEPARATION TECH- NOLOGY, ANTICIPATES THAT IT WILL DEVELOP A DIAGNOSTIC TEST FOR THESE ISOENZYMES WHICH WILL REQUIRE MINIMAL TECHNICAL HANDLING AND EXPERTISE AND WILL BE MORE ECONOMICAL THAN CURRENTLY USED LABORATORY TECHNIQUES.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government